Home > Rainbow Coral Corp. RBCC > Page 3

Tag: Rainbow Coral Corp. RBCC

FridayFeb 22, 2013 11:01 am

Rainbow Coral Corp. (RBCC) Targets the Latest Biotechnologies

Rainbow Coral, through their wholly-owned subsidiary Rainbow Biosciences, seeks partnership with biotechnology developers to deliver profitable new medical technologies and innovations, focusing on commercialization potential in key areas such as Alzheimer’s, Parkinson’s, and cancer. An example of the company’s activities is their joint venture partnership with Nano3D BioSciences (n3D), a Texas company with a unique technology for the rapid culturing of cells in three dimensions using magnetic levitation. Compared with conventional cell cultures grown on flat surfaces, these 3D cultures form tissues that more closely resemble those found in the human body. The technique has the potential to drastically reduce…

Continue Reading

WednesdayFeb 13, 2013 7:25 am

Rainbow Coral Corp. (RBCC) Sheds Light on Key Growth Plans, Engages New IR Group

Today before the opening bell, Rainbow Coral announced it is launching a new investor outreach campaign. The company has retained an up-and-coming, dynamic investor relations group committed to enhancing the visibility and reach of RBCC’s strategic growth initiatives. “Our new investor relations partners have the hands-on expertise and industry relevance we need to thoroughly communicate our corporate plans and activities to current and potential investors as timely and efficiently as possible,” stated RBCC CEO Patrick Brown. “We’re confident that 2013 is shaping up to be an incredible year for RBCC, and we want to make sure that it doesn’t go…

Continue Reading

MondayFeb 11, 2013 7:39 am

Rainbow Coral Corp. (RBCC) Leverages Innovation to Meet Demand

Rainbow Coral, via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer’s, Parkinson’s, and Cancer. Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere. The pending joint venture with Amarantus BioScience to develop…

Continue Reading

ThursdayJan 10, 2013 8:01 am

Rainbow Coral Corp. (RBCC) is “One to Watch”

Biotech subsidiary of Rainbow Coral Corp., Rainbow BioSciences, is making some big moves in the sector by joint venturing with hot properties that have short-term marketability and commercialization potential in key areas like Alzheimer’s, Parkinson’s (the wider neurological field), and Cancer. Constantly on the lookout for new biotech partnership opportunities at the leading conferences, RBCC keeps a keen eye on the sector and has made some shrewd plays that position shareholders for tremendously low-risk upside. RBCC is a tip-of-the-spear company pioneering new medical territory in a global biotech market that has ballooned to over $84.6B through strategic deals where the…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .